New York, July 11, 2018: The synthetic biology market is expected to exceed more than US$38 billion by 2020.
The synthetic biology market is segmented on the lines of its product, technology and application. The synthetic biology is segmented on the lines of its product are enabled products, core product and enabling products. The enabled product is further segmented into pharmaceuticals, chemicals, biofuels and agriculture. Under core product segmentation it covered synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms.
The enabling product is segmented into DNA synthesis and oligonucleotide synthesis. The synthetic biology is segmented on the lines of its technology like enabling technology and enabled technology. Under enabling technology it covers genome engineering, microfluidics technologies, DNA synthesis & sequencing technologies, bioinformatics technologies, biological components and integrated systems technologies. The enabled technology the market is segmented into pharmaceuticals, chemicals, biofuels and agriculture. Under application segmentation the market covered into research & development, chemicals, agriculture, pharmaceuticals & diagnostics, biofuels, environment, biotechnology and biomaterials.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include BASF, GEN9 Inc. , Algenol Biofuels , Codexis Inc. , GenScript Corporation , DuPont , Butamax Advanced Biofuels , BioAmber , Biosearch Technologies, Inc. , OriGene Technologies, Inc. , Synthetic Genomics, Inc. , GeneArt (Life Technologies) , GENEWIZ, Inc. , Eurofins Scientific, Inc. , Integrated DNA Technologies, Inc. , DNA2.0, Inc. , Pareto Biotechnologies , Synthorx, Inc. , TeselaGen Biotechnology , Editas Medicine, Inc. , Twist Bioscience , GeneWorks Pty Ltd. , Proterro, Inc. and Blue heron (OriGene technologies Inc.) . Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
You Can Browse Full Report @: https://www.marketresearchengine.com/reportdetails/synthetic-biology-market
The scope of the report includes a detailed study of global and regional markets for various types of synthetic biology with the reasons given for variations in the growth of the industry in certain regions.
The major driving factors of synthetic biology market are as follows:
- Financial support and assistance from government and private organizations.
- Increasing number of individual conducting research.
- Growing number of industries entering in the market.
- Declining price of DNA sequencing.
The restraints factors of synthetic biology market are as follows:
- Issue related bio-safety and bio-security
- Creation of strict regulatory bodies
- Formation of ethical challenges
This report provides:
1) An overview of the global market for synthetic biology and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.
3) Identifications of new market opportunities and targeted promotional plans for synthetic biology
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Request Sample Report: https://www.marketresearchengine.com/reportdetails/synthetic-biology-market
The Synthetic biology Market has been segmented as below:
The Global Synthetic biology Market is segmented on the basis of Product Analysis, Technology Analysis, Application Analysis and Regional Analysis .
By Product Analysis this market is segmented on the basis of Enabling Products, DNA Synthesis, Oligonucleotide Synthesis, Enabled Products, Pharmaceuticals, Chemicals, Biofuels, Agriculture, Core Products, Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA and Chassis Organisms. By Technology Analysis this market is segmented on the basis of Enabling Technology, Genome Engineering, Microfluidics technologies, DNA synthesis & sequencing technologies, Bioinformatics technologies, Biological components and integrated systems technologies, Enabled Technology, Pathway engineering, Synthetic microbial consortia and Biofuels technologies. By Application Analysis this market is segmented on the basis of Research & Development, Chemicals, Agriculture, Pharmaceuticals & Diagnostics, Biofuels and Others (Environment, Biotechnology & Biomaterials, etc.). By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Industry Speaks
6 Market Overview
6.2 Market Dynamics
220.127.116.11 Rising R&D Expenditure of Pharmaceutical and Biotechnology Companies
18.104.22.168 Increasing Demand for Synthetic Genes
22.214.171.124 Rise in the Global Production of Genetically Modified Crops
126.96.36.199 Increase in Funding
188.8.131.52 Ethical and Societal Issues
184.108.40.206 Standardization of Biological Parts
220.127.116.11 Rising Concerns on Fuel Consumption
18.104.22.168 Increasing Demand for Protein therapeutics
7 Industry Insights
8 Synthetic Biology Market, By Tool
9 Market, By Technology
10 Market, By Application
11 Synthetic Biology Market, By Geography
12 Competitive Landscape
13 Company Profiles
13.2 Amyris, Inc.
13.4 Genscript USA, Inc.
13.5 Intrexon Corporation
13.6 Integrated Dna Technologies (IDT), Inc.
13.7 New England Biolabs, Inc.
13.9 Royal DSM N.V.
13.10 Synthetic Genomics, Inc.
13.11 Thermo Fisher Scientific, Inc.
Company Name: Market Research Engine
Contact Person: John Bay
Email: [email protected]
Country: United States
The post Synthetic Biology Market Size Worth US$ 38 Billion By 2020 appeared first on Herald Keeper.